Trial · NCT04902105
Registered outcomes75
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 75
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cmax of ecopipam in the presence of mefenamic acid | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | Cmax of ecopipam in the absence of mefenamic acid | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | Cmax of ecopipam in the presence of divalproex sodium ER | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | Cmax of ecopipam in the absence of divalproex sodium ER | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | AUCinf of ecopipam in the presence of mefenamic acid | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | AUCinf of ecopipam in the absence of mefenamic acid | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | AUCinf of ecopipam in the presence of divalproex sodium ER | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | AUCinf of ecopipam in the absence of divalproex sodium ER | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | AUC0-143 of ecopipam in the presence of mefenamic acid | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | AUC0-143 of ecopipam in the absence of mefenamic acid | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | AUC0-143 of ecopipam in the presence of divalproex sodium ER | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Primary | AUC0-143 of ecopipam in the absence of divalproex sodium ER | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Secondary | Cmax of EBS-101-40853 | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Secondary | AUCinf of EBS-101-40853 | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Secondary | AUC0-143 of EBS-101-40853 | Up to Day 16 | Up to 35 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Secondary | Cmax of mefenamic acid | Up to Day 16 | Up to 15 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Secondary | Tmax of mefenamic acid | Up to Day 16 | Up to 15 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Secondary | AUCtau of mefenamic acid | Up to Day 16 | Up to 15 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Secondary | t½ of mefenamic acid | Up to Day 16 | Up to 15 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
| Secondary | Cmax of VPA | Up to Day 16 | Up to 19 blood samples will be collected at the indicated time points for pharmacokinetic analysis |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04902105/registered